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AbstrAct
Introduction This study aimed to examine the effect of 
socioeconomic deprivation on the outcomes of diabetes 
complications in patients with type 2 diabetes mellitus 
(T2DM).
Research design and methods We conducted a cohort 
study using claims data and 2005 national census data. We 
included of 7510 patients newly diagnosed with T2DM from 
2004 to 2012 and aged 40 years or above. We excluded 
participants who had onset of diabetes complications and 
hospitalization within 1 year after initial onset T2DM, aged 
less than 40 years and with missing covariates. We used 
the regional socioeconomic deprivation index and classified 
study participants into five categories according to the 
quintile distribution. We calculated the adjusted HR and 95% 
CI for hospitalization related to diabetes complications and 
all- cause mortality by applying Cox proportional hazards 
model and the adjusted subdistribution hazards model.
Results The percentages of participants in the first 
quintile (least deprived) to fifth quintile (most deprived) 
were 27.0%, 27.9%, 19.5%, 14.8%, and 10.8% for 
socioeconomic deprivation; 25.4%, 28.8%, 32.4%, 
34.6%, and 37.6% for hospitalization due to diabetes 
complications; 1.3%, 2.1%, 2.5%, 2.9%, and 3.6% for 
deaths from diabetes complications; and 5.7%, 7.2%, 
9.7%, 9.7%, and 13.1% for deaths from all causes, 
respectively. Participants with higher socioeconomic 
deprivation had a higher HR for hospitalization and 
mortality from all- cause and diabetes complications. 
These associations were the strongest among men and 
participants in their 40s in hospitalization related to 
diabetes complications, 50s in diabetes complications- 
specific mortality and 50s and 60s in all- cause mortality.
Conclusions Patients with T2DM with high socioeconomic 
deprivation had higher hospital admission and mortality 
rates for diabetes complications than those with 
low deprivation. We cannot fully explain the effect of 
socioeconomic deprivation on diabetes outcomes. 
Therefore, further studies are needed in order to find 
underlying mechanisms for these associations.
InTRoduCTIon
Diabetes is estimated to affect about 
415 million adults worldwide; 5.5 million 
deaths are caused by diabetes in 2015. The 
prevalence rate of diabetes continues to rise 
and is expected to reach 10.4% by 2040.1 
Patients with type 2 diabetes mellitus (T2DM) 
have a high risk of complications such as 
heart disease, stroke, renal disease, and 
retinopathy.2–5 Although the mortality rate 
among people with diabetes is decreasing, 
they remain at a significantly higher risk 
of developing these complications than 
people without diabetes.6 Individuals living 
in low- income households, as well as those 
significance of this study
What is already known about this subject?
 ► Individuals living in low- income households, as well 
as those of low socioeconomic status, have a higher 
risk of diabetes complications than those of other 
socioeconomic groups.
What are the new findings?
 ► Participants with higher socioeconomic deprivation 
have higher HR for hospital admission and mor-
tality from all- cause and diabetes complications 
compared with those with lower socioeconomic 
deprivation.
 ► These associations were the strongest among men 
and participants in their 40s in hospitalization re-
lated to diabetes complications, 50s in diabetes 
complications- specific mortality and 50s and 60s in 
all- cause mortality.
How might these results change the focus of 
research or clinical practice?
 ► The differences in medical and in social and eco-
nomic factors may play an important role in the 
outcomes of diabetes complications. Health policy 
makers and professionals should consider these 
factors when formulating preventive strategies for 
adverse diabetes outcomes.
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with low socioeconomic status, have a higher risk of 
diabetes complications than those of other socioeco-
nomic groups.7–10 Low socioeconomic status is associated 
with many factors known to contribute to poor health 
outcomes, including decreased access to recommended 
preventive care, low care utilization, poor metabolic 
control and psychological pain.10 In addition, previous 
studies have proven that the results of diabetes compli-
cations differ according to an individual’s socioeconomic 
status and from neighborhood to neighborhood.11–16
Socioeconomic deprivation encompasses the current 
individual socioeconomic status and social relationships, 
community- level characteristics and gradients of socio-
economic position at the individual and community 
level.10 17 18 Socioeconomic position is a complex structure 
based on socially derived economic factors that deter-
mine the relative status of an individual or group within a 
society. The differences in socioeconomic status between 
the social strata can lead to inequalities in health.13 19 20
Although many studies have assessed the association 
of socioeconomic deprivation with the incidence of 
diabetes complications and mortality due to diabetes, 
their study populations were mostly Western. This study 
aimed to examine the effect of socioeconomic depriva-




This study used a random sample of claims data from 
the Korean National Health Insurance Service, which 
included information about approximately 1 million 
patients. The data included unique anonymous number 
for each patient with age, sex, type of insurance, and a 
list of diagnoses according to the International Classifi-
cation of Diseases version 10 (ICD-10). The dataset also 
contained claimed medical costs, prescribed drugs, and 
medical history.
We conducted a cohort study of patients newly diag-
nosed with T2DM (ICD-10 code: E11, except for E11.9), 
using a 2.5% stratified random sample. From 13 893 
patients diagnosed as having T2DM from 2004 to 2012, 
we excluded patients with a pre- existing diagnosis of 
T2DM, diabetes complications, and the use of diabetes 
medication from 2002 to 2003. Accordingly, we selected 
9536 with newly diagnosed T2DM. Then, we excluded 
2026 patients who were aged <40 years, died of diabetes 
complications within 1 year after the onset of T2DM, 
or had missing covariates. Finally, 7510 patients were 
enrolled in the study.
Predictor variables
Data from the national census conducted in 2005 were 
used to assess the socioeconomic deprivation index. The 
data were a 2% random sample from the nationwide 
population and publicly accessible through the Micro-
data Service System provided by Statistics Korea.
We focused mainly on socioeconomic deprivation 
indices in 250 regions using the 2005 Korean census data. 
Areas with relatively large and heterogeneous popula-
tions, ranging from 12 000 to 630 000, which are adminis-
tratively defined in Korea as regions, were used as space 
units for analysis.21 A region is defined as the smallest city- 
state unit that can implement autonomous policies and 
the lowest statistical unit with official data. For area- level 
deprivation measures, the degree of urbanicity, which 
is designated by the government (metropolitan, urban, 
and rural), and a socioeconomic deprivation index was 
assigned to each region. The socioeconomic depriva-
tion index was generated by modifying the Townsend 
and Carstairs index, which has been used in previous 
studies21–23 and calculated by Kim and colleagues’ meth-
odology.21 For every region, we calculated the proportion 
of households: (1) living in an apartment, (2) without 
a car, (3) congested (>1.5 people/ room), (4) with a 
woman homeowner, (5) renting a home and (6) under 
substandard living conditions (without hot water supply, 
a flush toilet, or modern kitchen). In addition, we calcu-
lated the proportion of adults older than 25 years who 
were: (7) unemployed among high school graduates, 
(8) unemployed among the economically active, (9) 
employed manually and (10) who were older than 65 
years. All proportions were z- standardized; we did not 
include home ownership and unemployment rate in 
further analysis since the factor analysis with varimax 
rotation showed that these factors differ from the others. 
Finally, we averaged z- standardized scores of the eight 
remaining proportions (households living in an apart-
ment, households without cars, crowded conditions, 
women homeowners, and individuals with educational 
level lower than high school graduation among adults 
over 25 years of age) to constitute a regional deprivation 
index. A positive and high score implied a higher level 
of deprivation. We classified study participants into five 
categories according to the quintile distribution of the 
regional deprivation index (first quintile being least and 
fifth quintile most deprived).
Age was classified into four groups: 40–49, 50–59, 60–69, 
and ≥70 years. Household income was estimated using 
the health insurance premium and divided into tertiles. 
Medical aid was defined as non- payment of health insur-
ance premiums, low income as the bottom 20% of health 
insurance premiums, middle income as 20%–80% of the 
premiums, and high income as the top 20% of premiums. 
The Charlson comorbidity index (CCI) was calculated 
for 1 year before the onset of T2DM. We included the use 
of insulin during the follow- up period in the analysis.
outcome variables
We used ICD-10, fee- for- service, and prescribed drug 
codes to assess the incidence of T2DM, diabetes compli-
cations, hospital admissions, and mortality from diabetes 
complications including neurovascular disease, cardio-
vascular disease, end- stage renal disease, proliferative 
retinopathy, lower extremity arterial disease, diabetic 
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Figure 1 The socioeconomic deprivation scores according 
to the 250 regions.
foot, and autonomic neuropathy (online supplementary 
eTable 1). Mortality due to diabetes complication was 
defined as the occurrence of death 1 year following the 
onset of T2DM.
statistical analysis
The baseline characteristics of the study population were 
analyzed descriptively using the χ2 test, t- test, and analysis 
of variance. Thereafter, we calculated the adjusted HR 
and 95% CI for hospitalization related to diabetes compli-
cations and all- cause mortality by applying Cox propor-
tional hazards model, and the adjusted subdistribution 
HR (sHR) and 95% CI for diabetes complications- specific 
mortality by applying Cox proportional subdistribution 
hazards model. In this model, we adjusted for these 
regional and individual characteristics: sex, age, house-
hold income, types of insurance, CCI, disability status, 
use of insulin treatment, classification of hospital visited, 
and year of onset of T2DM. The follow- up time was calcu-
lated from the onset of T2DM to the time of death due 
to diabetes complications, loss to follow- up, death from 
another cause, or to the end of the study on 15 December 
2013 for those who did not have complications or did not 
die. Hence, the follow- up time was equivalent to the dura-
tion of diabetes. The number of hospital admissions and 
mortality rate due to diabetes complications, stratified 
by socioeconomic deprivation, were measured from the 
time of diagnosis, using the overall survival after 1 year of 
T2DM onset as the event variable. Lastly, we conducted 
subgroup analyses by sex and age. The rates of events 
were calculated as the number of events per 1000 person- 
years along with the 95% CI using the standard life table 
analysis technique. All statistical analyses were performed 
using SAS V.9.4 and R V.3.6 (The R Development Core 
Team, Vienna, Austria). Statistical significance was 
defined as p<0.05.
ResulTs
Figure 1 shows the socioeconomic deprivation scores 
according to the 250 regions. The deeper color represents 
a higher socioeconomic deprivation score than the light 
color. Socioeconomic deprivation scores ranged from 
−5.16 to 8.72.
Table 1 shows the overall demographic character-
istics of the study population. We observed a total of 
7510 participants with T2DM. The percentages of 
participants from the first quintile to the fifth quintile 
of socioeconomic deprivation were 27.0% (n=2027), 
27.9% (n=2096), 19.5% (n=1467), 14.8% (n=1111), and 
10.8% (n=809). According to socioeconomic deprivation 
groups from the first to the fifth quintile, 25.4% (n=514), 
28.8% (n=603), 32.4% (n=476), 34.6% (n=384), and 
37.6% (n=304) were hospitalized due to diabetes compli-
cations; 1.3% (n=26), 2.1% (n=44), 2.5% (n=36), 2.9% 
(n=32), and 3.6% (n=29) died from diabetes complica-
tions; and 5.7% (n=115), 7.2% (n=151), 9.7% (n=142), 
9.7% (n=108), and 13.1% (n=106) died from all causes, 
respectively (online supplementary eTable 2).
Figure 2 shows the cumulative incidence function of 
diabetes complications- specific mortality, other- cause 
mortality, and hospitalization with diabetes complica-
tions assessed using Gray’s test according to socioeco-
nomic deprivation with competing risks. The cumulative 
diabetes complications mortality and hospital admission 
rates for the fifth quintile group were higher than those 
for other groups (Gray’s test: p=0.0015). The diabetes 
complications- related mortality rates per 1000 patient- 
years were 1.83 (95% CI 1.26 to 2.67), 2.91 (95% CI 2.16 
to 3.91), 3.47 (95% CI 2.50 to 4.80), 4.04 (95% CI 2.86 
to 5.71), and 5.10 (95% CI 3.54 to 7.34) from the first 
quintile to the fifth quintile, respectively (online supple-
mentary eTable 3).
Table 2 shows the adjusted HRs of outcomes using Cox 
proportional subdistribution hazards models according 
to socioeconomic deprivation and covariates. The second 
(HR 1.15, 95% CI 1.02 to 1.30), third (HR 1.28, 95% CI 
1.13 to 1.45), fourth (HR 1.42, 95% CI 1.24 to 1.62) and 
fifth (HR 1.48, 95% CI 1.28 to 1.71) quintile of socioeco-
nomic deprivation had higher HRs for hospitalization 
related to diabetes complications compared with the 
first quintile. For mortality from diabetes complications, 
the sHRs of the third (sHR 1.72, 95% CI 1.03 to 2.87), 
fourth (sHR 2.07, 95% CI 1.22 to 3.51) and fifth (sHR 
2.38, 95% CI 1.39 to 4.07) quintile were higher than 
those of the first quintile. The third (HR 1.64, 95% CI 
1.28 to 2.11), fourth (HR 1.62, 95% CI 1.24 to 2.11), and 
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(least) Second quintile Third quintile Fourth quintile
Fifth quintile
(most)
P valueN % N % N % N % N % N %
Sex 0.013
  Men 4455 59.3 1237 61.0 1271 60.6 837 57.1 663 59.7 447 55.3
  Women 3055 40.7 790 39.0 825 39.4 630 42.9 448 40.3 362 44.7
Age (years) <0.001
  40–49 2273 30.3 678 33.4 662 31.6 429 29.2 314 28.3 190 23.5
  50–59 2519 33.5 701 34.6 694 33.1 483 32.9 378 34.0 263 32.5
  60–69 1773 23.6 440 21.7 486 23.2 356 24.3 267 24.0 224 27.7
  70+ 945 12.6 208 10.3 254 12.1 199 13.6 152 13.7 132 16.3
Household income <0.001
  First tertile 2898 38.6 686 33.8 750 35.8 622 42.4 453 40.8 387 47.8
  Second tertile 1983 26.4 543 26.8 527 25.1 386 26.3 306 27.5 221 27.3
  Third tertile 2629 35.0 798 39.4 819 39.1 459 31.3 352 31.7 201 24.8
Types of insurance <0.001
  Self- employed insured 
or NHI
6767 90.1 1891 93.3 1933 92.2 1287 87.7 970 87.3 686 84.8
  Medical aid 743 9.9 136 6.7 163 7.8 180 12.3 141 12.7 123 15.2
Charlson Comorbidity Index 0.172
  0 3724 49.6 1032 50.9 1070 51.0 702 47.9 518 46.6 402 49.7
  1 2457 32.7 650 32.1 674 32.2 489 33.3 392 35.3 252 31.1
  2+ 1329 17.7 345 17.0 352 16.8 276 18.8 201 18.1 155 19.2
Disability 0.461
  Healthy 6892 91.8 1871 92.3 1939 92.5 1331 90.7 1005 90.5 746 92.2
  Severe 158 2.1 43 2.1 39 1.9 35 2.4 25 2.3 16 2.0
  Mild 460 6.1 113 5.6 118 5.6 101 6.9 81 7.3 47 5.8
Onset of diabetes complications 0.461
  No 537 7.2 139 6.9 166 7.9 100 6.8 82 7.4 50 6.2
  Yes 6973 92.8 1888 93.1 1930 92.1 1367 93.2 1029 92.6 759 93.8
Insulin treatment 0.765
  No 7067 94.1 1908 94.1 1967 93.8 1381 94.1 1054 94.9 757 93.6
  Yes 443 5.9 119 5.9 129 6.2 86 5.9 57 5.1 52 6.4
Hospital classification <0.001
  General hospital 995 13.2 290 14.3 326 15.6 187 12.7 103 9.3 89 11.0
  Hospital 407 5.4 96 4.7 113 5.4 61 4.2 88 7.9 49 6.1
  Clinic 5597 74.5 1546 76.3 1543 73.6 1115 76.0 829 74.6 564 69.7
  Others 511 6.8 95 4.7 114 5.4 104 7.1 91 8.2 107 13.2
Year of onset type 2 diabetes 0.070
  2004 1967 26.2 528 26.0 529 25.2 391 26.7 289 26.0 230 28.4
  2005 1863 24.8 524 25.9 521 24.9 351 23.9 278 25.0 189 23.4
  2006 1195 15.9 309 15.2 372 17.7 226 15.4 170 15.3 118 14.6
  2007 564 7.5 173 8.5 156 7.4 113 7.7 72 6.5 50 6.2
  2008 801 10.7 188 9.3 197 9.4 184 12.5 126 11.3 106 13.1
  2009 444 5.9 120 5.9 120 5.7 82 5.6 71 6.4 51 6.3
  2010 268 3.6 75 3.7 75 3.6 54 3.7 39 3.5 25 3.1
  2011 280 3.7 75 3.7 88 4.2 41 2.8 51 4.6 25 3.1
  2012 128 1.7 35 1.7 38 1.8 25 1.7 15 1.4 15 1.9
Total 7510 100.0 2027 27.0 2096 27.9 1467 19.5 1111 14.8 809 10.8
NHI, National Health Insurance.
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Figure 2 Cumulative incidence function of DCSM and OCM and hospitalization with diabetes complications according to 
socioeconomic deprivation.
Table 2 The adjusted subdistribution HRs of outcomes using Cox proportional hazards models with competing risks 




(least) Second quintile Third quintile Fourth quintile
Fifth quintile
(most)
Reference HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Hospitalization with 
diabetes complications
1.00 1.15 (1.02 to 1.30) 1.28 (1.13 to 1.45) 1.42 (1.24 to 1.62) 1.48 (1.28 to 1.71)
Mortality with diabetes 
complications
1.00 1.60 (0.98 to 2.60) 1.72 (1.03 to 2.87) 2.07 (1.22 to 3.51) 2.38 (1.39 to 4.07)
All- cause mortality 1.00 1.22 (0.96 to 1.56) 1.64 (1.28 to 2.11) 1.62 (1.24 to 2.11) 2.05 (1.57 to 2.68)
Analysis was adjusted for the following covariates: sex, age, household income, types of insurance, Charlson Comorbidity Index, disability, 
onset of diabetes complications, insulin treatment, hospital classification, and year of onset type 2 diabetes.
fifth (HR 2.05, 95% CI 1.57 to 2.68) quintile had higher 
HR for all- cause mortality than the first quintile. The 
HR of the second quintile for all cause and the sHR of 
the second quintile for diabetes complications- specific 
mortality were not statistically significant.
Figure 3 shows the results of the subgroup analyses of 
adjusted sHR for diabetes- specific mortality using Cox 
proportional subdistribution hazards model and for 
hospitalization related to diabetes complications and all- 
cause mortality using Cox proportional hazards model. 
Among men, those in the second, third, fourth, and fifth 
quintile of socioeconomic deprivation had higher HR for 
hospitalization compared with those in the first quintile. 
Among women, however, only those in the fourth and 
fifth quintile showed significantly higher HR for hospital-
ization than those in the first quintile. For mortality from 
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Figure 3 Adjusted HR for hospitalization and all- cause mortality and adjusted subdistribution HR for diabetes complications 
mortality according to subgroups.
diabetes complications in men, the fourth and fifth quin-
tile had higher sHR than the first quintile. There were no 
statistically significant differences among women. Similar 
trends were observed for all- cause mortality. Among the 
participants in their 40s, only the third, fourth, and fifth 
quintile group had higher HRs for hospitalization than 
the first quartile group. However, similar trends were 
observed for the group of participants in only their 50s in 
diabetes complications- specific and in their 50s and 60s 
in all- cause mortality.
dIsCussIon
This study examined the effect of socioeconomic depri-
vation on mortality from diabetes complications among 
patients with T2DM under the national health insur-
ance system of Korea. Patients with T2DM with high 
socioeconomic deprivation had a significantly higher 
rate of diabetes- related outcomes and all- cause mortality 
than those with low socioeconomic deprivation, after 
controlling for a variety of covariates. Moreover, these 
associations were the strongest among men and partic-
ipants in their 40s in hospitalization related to diabetes 
complications, 50s in diabetes complications- specific 
mortality, and 50s and 60s in all- cause mortality.
Neighborhoods or communities can play an important 
role in the health status of residents through the avail-
ability of healthcare and general attitude to health and 
health behaviors.10 18 In South Korea, there is a difference 
in regional characteristics between the metropolitan and 
rural areas due to the surge in economic growth and 
modernization, and migration of population from rural 
to urban areas.24–26 Previous studies reported that rural 
areas had lower income, more unmet medical needs, 
higher proportion of people aged 65 years or above, poor 
accessibility to healthcare service, and underutilization 
of health service manpower compared with metropolitan 
areas.22 27–30 However, the degree of urbanity can neither 
explain our age subgroup results nor the fact that there 
were no significant differences in older patients. A study 
in the UK showed similar inverse association between 
socioeconomic status and the prevalence of T2DM in 
the middle years of life.7 This factor may not be able 
to explain the relationship between the prevalence of 
diabetes and the socioeconomic status, and it may even 
underestimate this relationship.
Previous studies have shown that deprivation level is 
associated with prevalence of T2DM, chronic diabetes 
complications, mortality, and hospitalization due to 
diabetes complications.31–37 The Whitehall study and the 
WHO multinational study showed that people of lower 
socioeconomic status had 1.7 times higher all- cause 
mortality and 2.1 times higher mortality from cardiovas-
cular disease than those in higher classes.38 A Swedish 
study showed that low neighborhood socioeconomic 
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status is associated with 1.1 times higher OR for coronary 
heart disease in men and 1.2 times in women.37 In patients 
with diabetes, factors such as low income, low education, 
and living in poor areas are related to higher smoking 
rates, less frequent blood sugar monitoring, less exercise, 
and poor access to primary and professional care.39–42 
Therefore, patients with diabetes living in economically 
disadvantaged areas are likely to have a high risk of hospi-
talization and mortality from all causes and diabetes 
complications. It is a reasonable hypothesis that these 
factors may partly or substantially explain our findings. 
However, this is an ecological study based on aggregated 
data at area level, and our results cannot distinguish 
between contextual and compositional effects.
The observed associations are stronger in men than 
in women. The differences in biology, culture, lifestyle, 
environment, and socioeconomic status between men 
and women may lead to differences in predisposition, 
development, and clinical presentation of cardiovascular 
diseases.43 Previous studies have reported that genetic 
effects, epigenetic mechanisms, nutritional factors, and 
sedentary lifestyle affect the risk and complications of 
diabetes differently in both sexes.44 We believe that 
men are likely to engage in unhealthy behavior such 
as binge drinking, heavy smoking, and consumption 
of non- nutritious foods. Together with high socioeco-
nomic deprivation, these factors have a synergistic effect 
on hospital admission and mortality due to diabetes 
complications.
In the subgroup analysis according to age groups, partic-
ipants in their 50s showed a strong relationship between 
socioeconomic deprivation and mortality from diabetes 
complications and all- cause mortality. A previous study 
demonstrated that a high proportion of working- age 
people are still dying from diabetes.1 One possible expla-
nation is that young patients are likely to be obese, have 
higher insulin resistance, and more aggressive treatment 
may be needed to control blood sugar levels.45 Another 
possibility may be the increased attention paid to medi-
cations prescribed to older people to control their blood 
sugar, suggesting the need to improve blood sugar 
management in young patients.46 47 Moreover, this could 
be the result of a survival effect, as people with diabetes 
in lower socioeconomic groups die prematurely due to 
complications such as cardiovascular disease.38
Some limitations of this study are worth mentioning. 
First, other important covariates may have been omitted, 
such as clinical data regarding body mass index, blood 
pressure, fasting glucose level, and hemoglobin A1c 
level; education level; health behaviors such as alcohol 
consumption, smoking, and physical activity; and 
other individual social factors. Although such factors 
are strongly associated with diabetes complications 
outcomes, they were not included because of the limited 
information available in the claims data. Moreover, we 
could not consider long- standing diabetes that went 
undiagnosed. Second, we could not consider the consis-
tency of individual socioeconomic deprivation within 
any region because of the lack of information. We could 
not differentiate between contextual and compositional 
effects because our findings are based on aggregated 
data at area level. This might have caused the inconsis-
tent results between men and women, age groups, and 
household income levels. Therefore, caution is needed 
when interpreting these results. Further studies need 
to consider both area- level and individual- level socio-
economic deprivation as factors that influence diabetes 
outcomes. Third, we could not measure diabetes severity. 
However, we tried to account for diabetes severity by 
including the use of insulin and CCI in our analysis. 
Fourth, although regional characteristics were adjusted 
using some regional information, we could not fully 
control regional factors because of the limitation of the 
data. Finally, we could not validate our study modeling 
approach and diagnosis of outcomes. To overcome this, 
we defined the diagnosis of outcomes using both ICD-10 
and medicine codes.
The present findings are valuable because of the 
following strengths of our study. First, we used a stratified 
random sample of a large and comprehensive national- 
level dataset, which included patients with diabetes with a 
long follow- up period, thus securing the external validity 
of the study. Second, as this study was an observational 
longitudinal cohort study, the association between the 
independent variables and survival is more confirma-
tive than it would have been if obtained using a cross- 
sectional study. Finally, we considered a subdistribution 
hazard model because the naive Kaplan- Meier analysis 
with competing events as censored observations may be 
biased.48 This model yields a measure of association that 
reflects both the association of diabetes with a cause- 
specific death and the contribution of competing events 
by actively maintaining individuals with and without 
diabetes in the risk set.49
In conclusion, patients with T2DM with high socio-
economic deprivation had higher hospitalization and 
mortality rates due to diabetes complications than those 
with low deprivation. This effect was strongest among 
men and participants in their 50s. Although we cannot 
fully explain the effect of socioeconomic deprivation 
on diabetes outcomes, we believe that the difference in 
social and economic factors, as well as in medical factors, 
may play a key role. Health policy makers and profes-
sionals should consider these factors when formulating 
preventive strategies for adverse diabetes outcomes.
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